No Detail Found!

Clinical efects of neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy on complications and recurrence in patients with advanced gastric cancer

Author(s)
Rui Wang Department of Chemoradiotherapy Center, Chengde Central Hospital, Chengde 067000, Hebei, China.
Meng Li Department of Chemoradiotherapy Center, Chengde Central Hospital, Chengde 067000, Hebei, China.
Yanjie Zheng Department of Chemoradiotherapy Center, Chengde Central Hospital, Chengde 067000, Hebei, China.
Wenbo Zhang Department of Chemoradiotherapy Center, Chengde Central Hospital, Chengde 067000, Hebei, China.
Ji Song Department of Chemoradiotherapy Center, Chengde Central Hospital, Chengde 067000, Hebei, China.
Fang Yang Department of Chemoradiotherapy Center, Chengde Central Hospital, Chengde 067000, Hebei, China.
Abstract
Objective: To compare the clinical efects of neoadjuvant chemoradiotherapy (NCRT) and neoadjuvant chemotherapy (NCT) on complications and recurrence in patients with advanced gastric cancer (AGC). Method: This was a retrospective study. A total of 83 patients with AGC admitted to Chengde Central Hospital between Jan. 2019 and Jun. 2021 were selected and divided into the observation group(n=41) and the control group(n=42) using a random number table. Patients in the control group received XELOX chemotherapy, and those in the observation group received intensity-modulated radiotherapy (IMRT) with concurrent XELOX chemotherapy. Compared eficacy, pathological complete response rate (pCR), R0 resection rate, adverse reactions, and quality of life (QOL) before and after treatment between the two groups. Results: The eficacy, pCR, and R0 resection rate of the observation group were significantly increased compared with those of the control group. Comparison of complications showed the number of patients experiencing gastrointestinal (GI) reactions, increased BUN, increased GPT, alopecia, and pigmentation in the observation group was decreased compared with that in the control group, with no statistically significant diferences(p>0.05), and the number of patients experiencing myelosuppression was statistically significant between the two groups(p0.05) before treatment. Conclusion: NCRT is safer and more efective in patients with AGC compared with NCT, and can significantly improve the QOL of patients. It can be widely used in clinical practice.
Publication Details
Page(s) 1556-1560
Published Journal: Pakistan Journal of Medical Sciences, Volume: 40, Issue: 7, Year: 2024

Request the full text from PASTIC

Keywords
complication, Neoadjuvant chemoradiotherapy, Advanced gastric cancer, Neoadjuvant chemotherapy
References
Sun G,Wang S,Liu G .2020 .Preoperative neoadjuvant chemotherapy on surgical condition and oncogene expression in advanced gastric cancer. Pak J Med Sci, 10(3) : 1608-489.
Jing SW,Qin JJ,Liu Q,Zhai C,Wu YJ,Cheng YJ .2019 .Comparison of neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for esophageal cancer: a meta-analysis. -0024, 10(20) : 2413-2422.
Ogun E,Ekrem UA,Yuksel C,Serdar C,Basceken SI,Umit M .2020 .. Laparoscopic Gastric Resection for Gastric Cancer: Is Intracorporeal Anastomosis Necessary? Pak J Med Sci, 10(6) : 1177-1182.
Jiang DM,Jiang H,Chung PWM,Zlotta AR,Fleshner NE,Bristow RG .2018 .Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic MuscleInvasive Bladder Cancer. Clin Genitourin Cancer, 09(1) : 38-45.
Sánchez-Izquierdo N,Perlaza P,Pagès M,Buxó E,Rios J,Rubello D .2020 .Assessment of Response to Neoadjuvant Chemoradiotherapy by 18F-FDG PET/CT in Patients With Locally Advanced Esophagogastric Junction Adenocarcinoma. Clin Nucl Med, 10(1) : 38-43.
Zhang Y,Yan L,Wu Y,Xu M,Liu X,Guan G. .2020 .Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer. BMC Cancer, 10(1) : 854.
Jang JK,Choi SH,Park SH,Kim KW,Kim HJ,Lee JS .2020 .MR tumor regression grade for pathological complete response in rectal cancer post neoadjuvant chemoradiotherapy: a systematic review and meta-analysis for accuracy. Eur Radiol, 10(4) : 2312-2323.
DE Felice F,Siniscalchi B,Bulzonetti N,Caiazzo R,Musio D,Tombolini V .2019 .Tolerability of Oxaliplatin-based Neoadjuvant Chemoradiotherapy in Elderly Locally Advanced Rectal Cancer Patients: A Case-control Study of a Real-life Experience. Anticancer Res, 10(12) : 6957-6963.
Li CC,Liang JA,Chung CY,Chen WT,Chien CR .2019 .Effectiveness of Intensity-Modulated Radiotherapy for Rectal Cancer Patients Treated with Neoadjuvant Concurrent Chemoradiotherapy: A Population-based Propensity Score-matched Analysis. Anticancer Res, 10(3) : 1479-1484.
Han S,Kim YI,Woo S,Kim TH,Ryu JS .2021 .Prognostic and predictive values of interim 18F-FDG PET during neoadjuvant chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis. Ann Nucl Med, 10(4) : 447-457.
Tokunaga M,Sato Y,Nakagawa M,Aburatani T,Matsuyama T,Nakajima Y .2020 .Perioperative chemotherapy for locally advanced gastric cancer in Japan: current and future perspectives. Surg Today, 10(1) : 30-37.
Liu S,Jiang T,Xiao L,Yang S,Liu Q,Gao Y .2021 .Total Neoadjuvant Therapy (TNT) versus Standard Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis. Oncologist, 10(9) : e1555-e1566.
Hayes IP,Milanzi E,Gibbs P,Reece JC .2020 .Neoadjuvant Chemoradiotherapy and Tumor Recurrence in Patients with Early T-Stage Cancer of the Lower Rectum. Ann Surg Oncol, 10(5) : 1570-1579.
Hakeem AR,Papoulas M,Menon KV .2018 .The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer - A systematic review. Eur J Surg Oncol, 08(2) : 83-91.
Ishida M,Ohno N,Sato H,Kitajima T,Deguchi M,Bou S .2019 .Neoadjuvant Proton Beam Chemoradiotherapy for Locally Advanced Gall Bladder Cancer-A Case Report]. , 46(13) : 1975-1977.
Murphy JE,Wo JY,Ryan DP,Clark JW,Jiang W,Yeap BY .2019 .Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial. JAMA Oncol, 10(7) : 1020-1027.
Han S,Choi SH,Choi DW,Heo JS,Han IW,Park DJ .2020 .Neoadjuvant therapy versus upfront surgery for borderlineresectable pancreatic cancer. Minerva Chir, 10(1) : 07958-6.
Liu X,Jin J,Cai H,Huang H,Zhao G,Zhou Y .2019 .Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT. BMC Cancer, 10(1) : 606.
Sun Q,Liu T,Liu P,Lu K,Zhang N,Liu L .2020 .Adjuvant chemotherapy for locally advanced rectal cancer in elderly patients after neoadjuvant chemoradiotherapy and surgery: Toxicity and survival outcomes. Medicine (Baltimore), 10(4) : .
0

Citations

0

Downloads

73

Views